Zhejiang Tailin BioEngineering Co.,Ltd (SHE:300813)

China flag China · Delayed Price · Currency is CNY
19.59
-0.31 (-1.56%)
Jun 11, 2026, 3:04 PM CST
Market Cap2.41B +11.0%
Revenue (ttm)339.54M -2.7%
Net Income16.49M +26.3%
EPS0.14 +16.7%
Shares Out 121.20M
PE Ratio142.14
Forward PEn/a
Dividend0.03 (0.15%)
Ex-Dividend DateMay 6, 2026
Volume1,607,140
Open20.08
Previous Close19.90
Day's Range19.21 - 20.08
52-Week Range18.67 - 42.25
Beta0.79
Analystsn/a
Price Targetn/a
Earnings DateAug 28, 2026

About SHE:300813

Zhejiang Tailin BioEngineering Co.,Ltd engages in the research and development, production, and sale of microbial detection, contamination control, process analysis, and inhibition protection in the life sciences field in China and internationally. The company primarily offers aseptic production and contamination control equipment, microbial testing products, and organic matter analysis technology products. It also provides pharma processing, such as pharma isolators, high-precision filling and dispensing, sterile transfer; cell and gene therap... [Read more]

Sector Healthcare
Founded 1993
Employees 790
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300813
Full Company Profile

Financial Performance

In 2025, SHE:300813's revenue was 339.54 million, a decrease of -2.71% compared to the previous year's 349.00 million. Earnings were 16.49 million, an increase of 26.32%.

Financial Statements